Drs. Katalin Kariko and Drew Weissman, inventors of the foundational RNA research that led to the COVID-19 vaccines, are two of researchers named by Time Magazine as their Heroes of the Year 2021.
Scout Bio, a Philadelphia company developing gene therapies for animal health, has licensed a new kind of technology from the Penn’s gene therapy program.
Passage Bio has exercised two additional options for potential new drug candidates under its research collaboration with Penn's gene therapy program.
Strategic partnership combines the start-ups’ revolutionary technologies for brain injury reduction and cognitive performance
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists.
The event honors the patent recipients from the previous fiscal year, as well as, those partners, inventors, and startups that made exceptional achievements.
The Penn Center for Innovation had the most-ever patents issued for Penn and its affiliates this year, according to the center's 2021 Year in Review.
With its highest number of patents issued, commercial agreements, corporate-sponsored research funding, and licensing revenue receipts in a single period, PCI experienced a landmark fiscal year.
Carter Caldwell, the Director of the Penn Medicine Co-Investment Program, wrote a guest blog for Penn Medicine News on how the University has impacted his life as a student, a patient, and an employee
Unique to both Penn and across higher education, the Prize underscores the University’s considerable commitment to encouraging students to put their knowledge to work for the betterment of humankind.